BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38456605)

  • 21. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
    Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
    Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
    Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
    Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 24. Rare papillary renal neoplasm with reverse polarity: A case report and review of the literature.
    Tu X; Zhuang X; Chen Q; Wang W; Huang C
    Front Oncol; 2023; 13():1101268. PubMed ID: 37007143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.
    Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ
    Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases.
    Zhou L; Xu J; Wang S; Yang X; Li C; Zhou J; Zhang P; Xu H; Wang C
    Int J Surg Pathol; 2020 Oct; 28(7):728-734. PubMed ID: 32403965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papillary renal neoplasm with reverse polarity with a favorable prognosis: Two cases report and literature review.
    Yuzhi Z; Zhen L; Yu X; Boju P; Weigang Y; Xingcheng W
    Front Oncol; 2022; 12():1011422. PubMed ID: 36387104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma.
    Kwon R; Argani P; Epstein JI; Lombardo KA; Wang X; Pierorazio PM; Mehra R; Matoso A
    Am J Surg Pathol; 2021 Apr; 45(4):450-462. PubMed ID: 33239504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.
    Saleeb RM; Farag M; Lichner Z; Brimo F; Bartlett J; Bjarnason G; Finelli A; Rontondo F; Downes MR; Yousef GM
    Mol Oncol; 2018 Oct; 12(10):1673-1688. PubMed ID: 29896907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
    Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases.
    Rogala J; Kojima F; Alaghehbandan R; Agaimy A; Martinek P; Ondic O; Ulamec M; Sperga M; Michalova K; Pivovarcikova K; Pitra T; Hora M; Ferak I; Marečková J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151441. PubMed ID: 31862520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
    Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
    Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
    Chan E; Stohr BA; Butler RS; Cox RM; Myles JL; Nguyen JK; Przybycin CG; Reynolds JP; Williamson SR; McKenney JK
    Am J Surg Pathol; 2022 Mar; 46(3):392-403. PubMed ID: 34881751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of papillary renal cell carcinoma. Clinicopathological, immunohistochemical features and its typing].
    Ono Y; Ito T; Tsujino S; Aizawa S; Suzuki M
    Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):587-95. PubMed ID: 9234615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
    Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
    Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
    Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
    Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma.
    Liu Y; Dong Y; Gu Y; Xu H; Fan Y; Li X; Dong L; Zhou L; Yang X; Wang C
    Ann Diagn Pathol; 2022 Oct; 60():152007. PubMed ID: 35841867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
    Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.